Gyre Therapeutics Inc. Working Capital to Net Assets Ratio
Gyre Therapeutics Inc. working capital to net assets ratio. Gyre Therapeutics Inc. (GYRE) has a Working Capital to Net Assets ratio of 52.5% as of March 2026. Working capital of $71.94 Million (current assets of $91.73 Million minus current liabilities of $19.79 Million) is measured against net assets of $136.99 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Gyre Therapeutics Inc. (GYRE) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Gyre Therapeutics Inc. (2004–2025)
Working capital to net assets ratio of Gyre Therapeutics Inc. from 2004 to 2025. This chart shows how Gyre Therapeutics Inc.'s Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 52.5%, reflecting working capital of $71.94 Million against net assets of $136.99 Million USD. See Gyre Therapeutics Inc. (GYRE) defensive interval to measure how many days the company can operate on defensive assets alone.
Gyre Therapeutics Inc. Working Capital to Net Assets Ratio by Year (2004–2025)
Gyre Therapeutics Inc. working capital to net assets ratio by year from 2004 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Gyre Therapeutics Inc. from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see GYRE total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 59.1% | $84.08 Million | $142.28 Million | $102.37 Million | $18.29 Million | ▲ +13.1 pp |
| 2024 | 46.0% | $45.27 Million | $98.40 Million | $64.79 Million | $19.52 Million | ▼ -220.5 pp |
| 2023 | 266.5% | $37.17 Million | $13.95 Million | $57.22 Million | $20.05 Million | ▲ +214.7 pp |
| 2022 | 51.8% | $37.41 Million | $72.22 Million | $49.65 Million | $12.24 Million | ▼ -39.0 pp |
| 2021 | 90.8% | $37.31 Million | $41.09 Million | $51.48 Million | $14.16 Million | ▼ -3.5 pp |
| 2020 | 94.3% | $71.71 Million | $76.07 Million | $89.51 Million | $17.80 Million | ▼ -4.0 pp |
| 2019 | 98.3% | $67.17 Million | $68.34 Million | $96.07 Million | $28.90 Million | ▼ -1.1 pp |
| 2018 | 99.4% | $119.19 Million | $119.94 Million | $123.99 Million | $4.80 Million | ▲ +0.7 pp |
| 2017 | 98.7% | $30.37 Million | $30.77 Million | $39.11 Million | $8.74 Million | ▲ +1.9 pp |
| 2016 | 96.8% | $15.56 Million | $16.07 Million | $37.52 Million | $21.96 Million | ▼ -1.7 pp |
| 2015 | 98.5% | $30.94 Million | $31.43 Million | $68.70 Million | $37.76 Million | ▲ +2.0 pp |
| 2014 | 96.5% | $105.23 Million | $109.08 Million | $108.14 Million | $2.91 Million | ▼ -3.1 pp |
| 2013 | 99.6% | $134.07 Million | $134.61 Million | $145.05 Million | $10.98 Million | ▼ -0.7 pp |
| 2012 | 100.3% | $176.36 Million | $175.91 Million | $187.71 Million | $11.35 Million | ▲ +31.4 pp |
| 2011 | 68.9% | $120.08 Million | $174.29 Million | $198.69 Million | $78.61 Million | ▼ -61.1 pp |
| 2010 | 130.0% | $119.42 Million | $91.85 Million | $218.08 Million | $98.66 Million | ▼ -179.1 pp |
| 2009 | 309.1% | $213.27 Million | $68.99 Million | $314.43 Million | $101.16 Million | ▲ +172.9 pp |
| 2008 | 136.3% | $78.17 Million | $57.37 Million | $91.97 Million | $13.79 Million | ▼ -13.4 pp |
| 2007 | 149.7% | $77.22 Million | $51.58 Million | $92.41 Million | $15.20 Million | ▲ +42.1 pp |
| 2006 | 107.5% | $69.90 Million | $65.00 Million | $78.85 Million | $8.95 Million | ▲ +120.2 pp |
| 2005 | -12.6% | $20.53 Million | $-162.48 Million | $25.74 Million | $5.21 Million | ▲ +28.1 pp |
| 2004 | -40.7% | $50.08 Million | $-122.97 Million | $55.39 Million | $5.31 Million | — |